Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates.
about
Osmotherapy for elevated intracranial pressure: a critical reappraisalPharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosingDisposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy.Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral lamivudine in human immunodeficiency virus-infected children.Preclinical aspects of lamivudine and famciclovir against hepatitis B virus.Pharmacokinetics of beta-L-2',3'-dideoxy-5-fluorocytidine in rhesus monkeysHIV, dementia and antiretroviral drugs: 30 years of an epidemic.Antiviral activity and pharmacokinetics of 1-(2,3-dideoxy-2-fluoro-beta-L-glyceropent-2-enofuranosyl)cytosine.Pharmacokinetics of (-)-2'-3'-dideoxy-3'-thiacytidine in woodchucksKinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patientsFactors affecting delivery of antiviral drugs to the brain.Minimally Invasive Lumbar Port System for the Collection of Cerebrospinal Fluid from Rhesus Macaques (Macaca mulatta)Antiretroviral bioanalysis methods of tissues and body biofluids.Drug interactions at the blood-brain barrier: fact or fantasy?Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment.Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico, In Vitro, and In Vivo Investigation.Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.DPC 817: a cytidine nucleoside analog with activity against zidovudine- and lamivudine-resistant viral variants
P2860
Q28370055-D84974FD-A0F2-486D-B46B-D1CF09800E45Q33694444-44EF8103-FEED-4C95-BA3A-48ABDB88DF71Q33694884-34389E6C-620B-4AA4-8A2D-CF2178E6246EQ33703360-77E074CF-4664-4119-9A2C-9CFB888EF23CQ33801322-F6BBCA00-336C-48DA-B294-0680C440C03BQ33976709-DBD940E2-C448-445C-8EFF-5634105DF56CQ34573511-F7BA7344-D389-4C99-9483-3509890197B6Q35013945-D935B2C9-3E1F-4A93-B001-4B495D1FD880Q35123010-4F603720-3814-4237-8B5A-9146D55967D7Q35135900-BF70B130-55C1-4E3B-BEA9-D058B0AC043EQ35951650-EAAA90B2-83D6-4843-B359-F1A984029A93Q37171777-EE6982EE-69C6-4C49-A406-06FDD001B4E4Q37332868-6546F291-3161-4226-8737-69A3EC008647Q37362486-06D4CB46-04F4-4B2E-9C20-02F36DEA6A64Q37492836-F00E3AAF-CEC2-49B5-8E40-4F6E634D790BQ37538717-3481B003-3910-44F3-B4D6-FFFAA48DDBBFQ38247035-F4302201-F8A2-43D9-9347-A38971E805B0Q39651722-F1B777C5-25E4-491F-9B40-1AF19072DFA0
P2860
Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates.
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Pharmacokinetics of lamivudine ...... al fluid of nonhuman primates.
@ast
Pharmacokinetics of lamivudine ...... al fluid of nonhuman primates.
@en
type
label
Pharmacokinetics of lamivudine ...... al fluid of nonhuman primates.
@ast
Pharmacokinetics of lamivudine ...... al fluid of nonhuman primates.
@en
prefLabel
Pharmacokinetics of lamivudine ...... al fluid of nonhuman primates.
@ast
Pharmacokinetics of lamivudine ...... al fluid of nonhuman primates.
@en
P2093
P2860
P356
P1476
Pharmacokinetics of lamivudine ...... al fluid of nonhuman primates.
@en
P2093
P2860
P304
P356
10.1128/AAC.39.12.2779
P407
P577
1995-12-01T00:00:00Z